AU3594293A - (Non descriptive)-a method for delaying HIV individual aids by administration of substituted azaspirane compounds - Google Patents

(Non descriptive)-a method for delaying HIV individual aids by administration of substituted azaspirane compounds

Info

Publication number
AU3594293A
AU3594293A AU35942/93A AU3594293A AU3594293A AU 3594293 A AU3594293 A AU 3594293A AU 35942/93 A AU35942/93 A AU 35942/93A AU 3594293 A AU3594293 A AU 3594293A AU 3594293 A AU3594293 A AU 3594293A
Authority
AU
Australia
Prior art keywords
administration
individual aids
delaying
descriptive
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35942/93A
Inventor
Alison Mary Badger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU3594293A publication Critical patent/AU3594293A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
AU35942/93A 1992-01-28 1993-01-27 (Non descriptive)-a method for delaying HIV individual aids by administration of substituted azaspirane compounds Abandoned AU3594293A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9201804 1992-01-28
GB929201804A GB9201804D0 (en) 1992-01-28 1992-01-28 Methods

Publications (1)

Publication Number Publication Date
AU3594293A true AU3594293A (en) 1993-09-03

Family

ID=10709399

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35942/93A Abandoned AU3594293A (en) 1992-01-28 1993-01-27 (Non descriptive)-a method for delaying HIV individual aids by administration of substituted azaspirane compounds

Country Status (5)

Country Link
EP (1) EP0727993A1 (en)
JP (1) JPH07504405A (en)
AU (1) AU3594293A (en)
GB (1) GB9201804D0 (en)
WO (1) WO1993015735A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT100566B (en) * 1991-06-07 1999-06-30 Smithkline Beecham Corp IMMUNOMODULATOR AZASPIRANES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
PT100566B (en) * 1991-06-07 1999-06-30 Smithkline Beecham Corp IMMUNOMODULATOR AZASPIRANES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE

Also Published As

Publication number Publication date
EP0727993A4 (en) 1996-10-02
WO1993015735A1 (en) 1993-08-19
EP0727993A1 (en) 1996-08-28
JPH07504405A (en) 1995-05-18
GB9201804D0 (en) 1992-03-11

Similar Documents

Publication Publication Date Title
AU4033093A (en) Methods for retarding blister formation by use of cyanoacrylate adhesives
AU5159490A (en) Composition and method for administration of pharmaceutically active substances
AU6998394A (en) Arylidene-4-oxo-2-thioxo-3-thiazolidine carboxylic aids, method of preparing them and drugs containing such compounds
AU2407492A (en) Compounds and methods for inhibition of hiv and related viruses
AU681569B3 (en) Process for the preparation of clavulanic acid
AU5441096A (en) Analogs of growth hormone-releasing factor
AU7786387A (en) Composition of matter and method of immunizing against viral causative agents of aids and arc
AU4932493A (en) An immunobooster for delayed release of immunogen
AU591958B2 (en) Method for production of stable nicorandil preparation
AU1397892A (en) New crystallised microporous gallium phosphate and its substituted derivatives and a method of preparing them
AU1161292A (en) Azabicydic and azatricydic derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
AU631025B2 (en) N-substituted derivatives of 3r, 4r-ethyl-((1-methyl-1h -imidazol-5-yl)methyl)-2-pyrrolidinone
AU4260089A (en) Method of preparing galactooligosaccharides
AU3239793A (en) Composition and method for improving oral bioavailability of carbamazepine
HU9200746D0 (en) Method for producing compounds of gallium and pharmaceutical preparatives containing them as active substance
PL299369A1 (en) Novel epoxy compounds, method of obtainining them and pharmaceutical preparation containing them
AU3594293A (en) (Non descriptive)-a method for delaying HIV individual aids by administration of substituted azaspirane compounds
AU5168496A (en) Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same
AU1078692A (en) Process for infusion of partially-defatted nuts
AU1152897A (en) Preparation method of physiologically active compound
AU1316188A (en) Method of inhibiting interleukin-1 release
AU4249793A (en) An improved method for preparation of glycosides
AU2254392A (en) Method for the preparation of niobium nitride
AU7482696A (en) Methods for administration of il-12
AU2934792A (en) Process for the preparation of trialkyl gallium compounds